Physician profile
Tracy Picmann
NPI 1225566250
$1,017.72
in general payments reported to CMS, 2019-2025
11 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $139 · 2022: $74.46 · 2023: $357 · 2024: $182 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $804.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $260.06 | 2021-2023 | Fasenra, Breztri |
| Lilly USA, LLC | $172.72 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Actelion Pharmaceuticals US, INC. | $125.00 | 2024 | Opsumit, Uptravi |
| Genzyme Corporation | $124.74 | 2025 | |
| Exact Sciences Corporation | $96.16 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Abbvie INC. | $88.77 | 2022-2023 | |
| Pfizer INC. | $78.22 | 2023-2025 | |
| Glaxosmithkline, LLC. | $20.53 | 2025 | Arexvy, Trelegy Ellipta |
| Supernus Pharmaceuticals, INC. | $20.34 | 2025 | Qelbree |
| Novo Nordisk INC | $17.33 | 2024 | Ozempic, Rybelsus |
| Amarin Pharma, INC. | $13.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Picmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.